sanofi logo
regeneron logo

Sanofi and Regeneron Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol

- All six trials met primary efficacy endpoint -

- Data presented at AHA Scientific Sessions 2014 -

/ PR Newswire / — Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced new detailed positive results from six Phase 3 ODYSSEY trials that showed alirocumab significantly reduced low-density lipoprotein cholesterol (LDL-C, or “bad” cholesterol). Alirocumab is an investigational fully human monoclonal antibody targeting the protein PCSK9 (proprotein convertase subtilisin/kexin type 9) that is being evaluated for its ability to lower LDL-C.
Read More

All six trials, ODYSSEY LONG TERM, COMBO I, ALTERNATIVE, OPTIONS I, OPTIONS II, and HIGH FH, met their primary efficacy endpoint of a greater reduction in LDL-C at 24 weeks, versus either active comparator or placebo, which included standard-of-care therapy. Detailed results from these trials were presented as part of a special session on the ODYSSEY program today, and on November 17 during a late-breaker presentation at the American Heart Association (AHA) Scientific Sessions in Chicago, IL. The companies had announced in July that all six studies met their primary efficacy endpoints.

Click here to read the full release.

Embed Code
x
<iframe id='inlineFrameId' name='inlineframe' src="http://www.multivu.com/players/English/7298631-sanofi-regeneron-pharmaceuticals-announce-positive-results-alirocumab-trials-at-esc-congress/embed.html" frameborder="0" scrolling="no" width="512" height="384" marginwidth="0" marginheight="0" ></iframe>
<OBJECT id="impID3e9509df-4f60-4dad-8fc6-d7903157fab7" type="application/x-shockwave-flash" data="http://www.multivu.com/players/English/7298631-sanofi-regeneron-pharmaceuticals-announce-positive-results-alirocumab-trials-at-esc-congress/flexSwf/3e9509df-4f60-4dad-8fc6-d7903157fab7.512x384.swf" width="512" height="384"><PARAM NAME="movie" VALUE="http://www.multivu.com/players/English/7298631-sanofi-regeneron-pharmaceuticals-announce-positive-results-alirocumab-trials-at-esc-congress/flexSwf/3e9509df-4f60-4dad-8fc6-d7903157fab7.512x384.swf"><PARAM NAME="quality" VALUE=high><PARAM NAME="wmode" VALUE="transparent"><PARAM NAME="allowScriptAccess" VALUE="always"><PARAM NAME="allowFullScreen" VALUE="true"><a href="http://www.multivu.com/players/English/7298631-sanofi-regeneron-pharmaceuticals-announce-positive-results-alirocumab-trials-at-esc-congress">Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014</a></OBJECT>